Join the club for FREE to access the whole archive and other member benefits.
Non-profit organization that funds research, Riyadh, Saudi Arabia
The Hevolution foundation aims to improve human health, prevent diseases, contribute to its treatment, and extend its healthy lifespan by supporting local and international efforts in those areas.
It was established by order of the King of the Kingdom of Saudi Arabia, Salman bin Abdulaziz Al Saud in December 2018 , and issued a statute for it that includes 18 articles explaining the purpose of the foundation and articles related to its board of trustees, and others related to its administrative and financial affairs and articles regulating the work of the foundation.
Our Vision: To extend a healthy lifespan for the benefit of all humanity
Our Mission: To drive efforts to extend a healthy human lifespan and understand the processes of aging, leveraging a broad set of tools through diverse approaches.
In particular, we aim to:
• Increase the number of safe and effective treatments entering the market
• Compress the timeline of drug development, using the latest tools and technologies
• Increase accessibility to therapeutics that extend healthy lifespan
• Mohammed bin Salman bin Abdulaziz Al-Saud, Chairman of the Board
• Mehmood Khan, Chief Executive Officer
• Felipe Sierra, Chief Scientific Officer
• Felipe Sierra
• Brian Kennedy
• Guido Kroemer
• Andrea Maier
• Laura Niedernhofer
• Thomas Rando
Visit website: https://www.hevolutionfoundation.com/
Details last updated 08-Jun-2022
Professor of Biochemistry, Molecular Biology and Biophysics at the University of Minnesota
04-Feb-2025
Longevity summit organised by Hevolution Foundation (Riyadh,Saudi Arabia)
29-Nov-2023 to 30-Nov-2023
Longevity summit organised by Hevolution Foundation (Riyadh,Saudi Arabia)
Crown Prince and Prime Minister of Saudi Arabia, Chairman of the Board at the Hevolution Foundation
New funding propels innovative mitophagy-inducing lead compound into clinical trials targeting Alzheimer’s and Parkinson’s
Up to $2.5m per project to contribute to cutting-edge research in the field of ageing biology and geroscience
Funds to advance compounds that target mTORC1 pathway for treating rare and age-related conditions
Event focused on extending quality life years through scientific innovation
Report suggests that our focus needs to move from lifespan to healthspan
10 years of functional age-reversal in 65-80 year olds within the next 7 years... bring it on!!!
Nine innovative projects, spread over seven US institutions, set to receive funding
More than 90% of drugs safe and effective when tested in experimental animals fail in human testing
Considering funding a $100 million age reversal X Prize and the TAME(metformin) trial
